Michael Morrison, Edison Bicudo. Producing Value or Responding to Valuation? SMEs’ Strategies for Commercialising Induced Pluripotent Stem Cell and Bioprinting Technology. Science & Technology Studies. 2026. doi:10.23987/sts.149468
Donna S. Macmillan, Phi Holcomb, Kristie M. Sullivan. Lost in NAMs-lation: A review of animal-free science definitions. ALTEX - Alternatives to Animal Experimentation. 2026. doi:10.14573/altex.2512221
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler. Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs-On-Chips. Advanced Biology. 2026;10(2):e00536. doi:10.1002/adbi.202500536
Patrizia Tornabene, Estelle Berreur, Adrian Roth, Magdalena Kasendra. Microphysiological systems to accelerate and de-risk AAV gene therapy development. Advanced Drug Delivery Reviews. 2026;233:115841. doi:10.1016/j.addr.2026.115841
Melissa V. Olson. Institutional Biobanking as Shared Public Health Infrastructure: A Financially Sustainable Service Center Model. Frontiers in Health Services. 2026;6. doi:10.3389/frhs.2026.1778446
Arianne Caudal, Joseph C. Wu. NAMing the challenges and opportunities of new approach methodologies for studying cardiovascular metabolism. Cell Metabolism. 2026;38(3):439-440. doi:10.1016/j.cmet.2025.12.021
Zoltan Arany. New approach methodologies: Don’t throw the baby out with the bathwater. Cell Metabolism. 2026;38(3):441-442. doi:10.1016/j.cmet.2026.01.009
Xuekun Wu, Matthew A. Wu, James Zou, Nicole Kleinstreuer, Joseph C. Wu. Reimagining human-centric drug development with new approach methodologies. Science. 2026:eaeb0045. doi:10.1126/science.aeb0045